Stockscreener 앱 받기
10.62
0.94%
-0.125
전일 마감가:
$10.74
열려 있는:
$10.63
하루 거래량:
38,164
Relative Volume:
0.03
시가총액:
$673.52M
수익:
$65,400
순이익/손실:
$-46.34M
주가수익비율:
-12.34
EPS:
-0.86
순현금흐름:
$-38.74M
1주 성능:
-3.28%
1개월 성능:
-5.01%
6개월 성능:
+109.43%
1년 성능:
+193.90%
1일 변동 폭
$10.54
$10.80
1주일 범위
$10.16
$11.41
52주 변동 폭
$2.89
$13.85
CorMedix Inc Stock (CRMD) Company Profile
명칭
CorMedix Inc
전화
908-517-9500
주소
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
CRMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| CRMD | 10.64 | 673.52M | 65,400 | -46.34M | -38.74M | -0.86 |
| VRTX | 447.79 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 742.25 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 590.72 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.74 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.50 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-02-17 | 개시 | Needham | Buy |
| 2020-09-29 | 개시 | JMP Securities | Mkt Outperform |
| 2020-09-21 | 개시 | Truist | Buy |
| 2019-12-18 | 개시 | B. Riley FBR | Buy |
| 2019-03-26 | 재확인 | H.C. Wainwright | Buy |
| 2018-12-06 | 개시 | ROTH Capital | Buy |
| 2017-09-25 | 재확인 | H.C. Wainwright | Buy |
| 2017-08-10 | 재확인 | Rodman & Renshaw | Buy |
| 2017-05-05 | 재확인 | Rodman & Renshaw | Buy |
| 2016-11-11 | 재확인 | FBR & Co. | Outperform |
| 2016-03-17 | 재확인 | FBR Capital | Outperform |
| 2016-03-03 | 개시 | FBR Capital | Outperform |
| 2015-11-16 | 재확인 | ROTH Capital | Neutral |
| 2015-10-29 | 재확인 | ROTH Capital | Neutral |
| 2015-05-06 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2014-12-08 | 재확인 | ROTH Capital | Buy |
| 2011-10-03 | 다운그레이드 | Maxim Group | Buy → Hold |
모두보기
CorMedix Inc 주식(CRMD)의 최신 뉴스
Cormedix EVP Elizabeth Hurlburt sells $1.57m in stock - Investing.com
When the Price of (CRMD) Talks, People Listen - Stock Traders Daily
Nomura Holdings Inc's Strategic Reduction in CorMedix Inc Shares - GuruFocus.com
Here's Why CorMedix Inc.'s (NASDAQ:CRMD) CEO Compensation Is The Least Of Shareholders' Concerns - Simply Wall St
CorMedix (CRMD) Upgraded to Strong Buy: What Does It Mean for the Stock? - MSN
Best Momentum Stocks To Buy For November 8th - Barchart
Best Momentum Stocks to Buy for November 8th - Yahoo Finance
Trend Tracker for (CRMD) - Stock Traders Daily
CorMedix's SWOT analysis: defencath launch boosts stock outlook By Investing.com - Investing.com Australia
CorMedix's SWOT analysis: defencath launch boosts stock outlook - Investing.com India
Wall Street Analysts See a 52.15% Upside in CorMedix (CRMD): Can the Stock Really Move This High? - Yahoo Finance
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium - The Manila Times
Analysts Just Made A Massive Upgrade To Their CorMedix Inc. (NASDAQ:CRMD) Forecasts - Simply Wall St
Rainbows and Unicorns: CorMedix Inc. (NASDAQ:CRMD) Analysts Just Became A Lot More Optimistic - Yahoo Finance UK
CorMedix: Q3 Earnings Snapshot - AOL
While shareholders of CorMedix (NASDAQ:CRMD) are in the black over 1 year, those who bought a week ago aren't so fortunate - Yahoo Finance
Recent 23% pullback isn't enough to hurt long-term CorMedix (NASDAQ:CRMD) shareholders, they're still up 188% over 1 year - Simply Wall St
CorMedix Inc. (NASDAQ:CRMD) Q3 2024 Earnings Call Transcript - Insider Monkey
CorMedix (CRMD) Reports Q3 Loss, Tops Revenue Estimates - MSN
CorMedix Inc. Reports Q3 2024 Financial Results - TipRanks
CorMedix (CRMD) Q3 2024 Earnings Call Transcript - The Motley Fool
Earnings call: CorMedix Inc. reports Q3 financials, DefenCath drives growth By Investing.com - Investing.com South Africa
Earnings call: CorMedix Inc. reports Q3 financials, DefenCath drives growth - Investing.com
CorMedix Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update - The Manila Times
CorMedix earnings beat by $0.06, revenue topped estimates - Investing.com UK
Stellantis N.V. (STLA-N) QuotePress Release - The Globe and Mail
Cormedix Inc (CRMD) Q3 2024 Earnings Report Preview: What To Loo - GuruFocus.com
CorMedix stock soars to 52-week high, hits $13.52 - Investing.com India
CorMedix 2.0: New Leadership, New Approval, New Focus (NASDAQ:CRMD) - Seeking Alpha
CorMedix stock soars to 52-week high, hits $13.52 By Investing.com - Investing.com UK
(CRMD) Trading Advice - Stock Traders Daily
Undercovered Dozen: CorMedix, Cabaletta, Skyx Platforms, Dynex Capital + - Seeking Alpha
Spotify Technology S.A. (SPOT-N) QuotePress Release - The Globe and Mail
CorMedix Inc. Announces New Data at ASN Kidney Week 2024 - The Manila Times
Wall Street Analysts Believe CorMedix (CRMD) Could Rally 142.25%: Here's is How to Trade - MSN
Mauritian Rupee/U.S. Dollar (MURUSD) QuotePress Release - The Globe and Mail
CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024 - The Manila Times
CorMedix Inc. (CRMD): A Bull Case Theory - Insider Monkey
CorMedix stock soars to 52-week high, hits $11.07 By Investing.com - Investing.com Australia
CorMedix Inc (CRMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
0.16%
자본화:
|
볼륨(24시간):